我们的网站为什么显示成这样?

可能因为您的浏览器不支持样式,您可以更新您的浏览器到最新版本,以获取对此功能的支持,访问下面的网站,获取关于浏览器的信息:

|本期目录/Table of Contents|

间充质干细胞分泌的血管内皮生长因子对心肌细胞的保护作用

《心脏杂志》[ISSN:1009-7236/CN:61-1268/R]

期数:
2013年第1期
页码:
17-021
栏目:
基础研究
出版日期:
2013-02-25

文章信息/Info

Title:
Effect of vascular endothelial growth factor from mesenchymal stem cells on antiapoptosis of H9C2 cells through PI3K/Akt signal pathway
作者:
毛洪波1邹赛1唐俊明23王家宁2孔霞2郑飞2杨建业2
(1.竹溪县人民医院内科,湖北 竹溪 442300;湖北医药学院:2.附属人民医院临床医学研究所,3.生理学教研室,湖北 十堰 442000)
Author(s):
MAO Hongbo1 ZOU Sai1 TANG Junming23 WANG Jianing2 KONG Xia2 ZHENG Fei2 YANG Jianye2
(1.Department of Cardiology, Zhuxi People’s Hospital, Zhuxi 442300, Hubei, China; 2.Institute of Clinical Medicine, People’s Hospital, 3.Department of Physiology, Hubei University of Medicine, Shiyan 442000, Hubei, Chin)
关键词:
间充质干细胞H9C2细胞血管内皮生长因子凋亡PI3K/Akt
Keywords:
mesenchymal stem cells H9C2 vascular endothelial growth factor apoptosis PI3K/Akt
分类号:
Q25;R542.2
DOI:
-
文献标识码:
A
摘要:
目的:探索间充质干细胞通过其分泌的血管内皮生长因子对H9C2细胞的保护作用及机制。方法: 收集骨髓源间充质干细胞的条件培养基,分别处理培养,将其置于缺氧小室缺氧处理21 h,复氧处理6 h。阻断实验利用VEGFR阻断剂SU5416与间充质干细胞的条件培养基共处理。随后,利用流式细胞术ANNEXIN/PI双标法分析其凋亡变化。Western blotting分析H9C2细胞pAkt的表达。结果: RTPCR结果显示间充质干细胞表达血管内皮生长因子,Western blotting结果显示间充质干细胞条件培养基增加了H9C2细胞pAkt的水平。AnnexinV/PI分析发现间充质干细胞条件培养基明显降低了H9C2细胞缺氧复氧的凋亡,且这种抗凋亡作用能被VEGFR阻断剂SU5416或PI3K/Akt途径阻断剂LY294002所阻断。结论: 间充质干细胞通过其分泌的血管内皮生长因子通过激活PI3K/Akt途径保护H9C2细胞。
Abstract:
AIM:To explore the effect of vascular endothelial growth factor (VEGF) from mesenchymal stem cells (MSCs) on antiapoptosis of H9C2 cells. METHODS: In vitro, condition medium (CM) from MSCs was collected after MSCs were cultured for 2 days. After H9C2 cells were pretreated with VEGFR inhibitor SU5416 (5 μmol/L) or PI3K/Akt inhibitor LY294002 (10 μmol/L) for 1 h, apoptosis of the cells was observed under hypoxia with Annexin V and PI double staining by flow cytometry. The expressions of Akt and pAkt in H9c2 cells were detected by Western blotting and expressions of VEGF in MSCs were detected by RTPCR. RESULTS: RTPCR showed the expression of VEGF on MSCs, and Western blotting showed increased levels of pAkt protein in H9C2 cells after treatment with CM. CM decreased H9C2 cell apoptosis but the antiapoptotic effect of the CM was blocked by VEGFR inhibitor SU5416 or PI3K/Akt inhibitor LY294002 (10 μmol/L), respectively. CONCLUSION: VEGF from MSCs plays an important role in the protection of H9C2 cells through PI3K/Akt signal pathway.

参考文献/References

[1]Tang J,Xie Q,Pan G,et al.Mesenchymal stem cells participate in angiogenesis and improve heart function in rat model of myocardial ischemia with reperfusion[J].Eur J Cardio thoracic Surg,2006,3(2):353-361.

[2]唐俊明,王家宁,杨建业,等.移植的间充质干细胞与宿主心肌匹配整合实验研究[J].南方医科大学学报,2007,27(1):38-42.

[3]Tang JM,Wang JN,Zhang L,et al.VEGF/SDF1 promotes cardiac stem cell mobilization and myocardial repair in the infarcted heart[J].Cardiovasc Res,2011,91(3):402-411.

[4]Tang J,Wang J,Kong X,et al.Vascular endothelial growth factor promotes cardiac stem cell migration via the PI3K/Akt pathway[J].Exp Cell Res,2009,315(20):3521-3531.

[5]Chen LW,Tredget E,Wu P,et al.Paracrine Factors of Mesenchymal Stem Cells Recruit Macrophages and Endothelial Lineage Cells and Enhance Wound Healing[J].PLoS ONE,2008,3(4):e1886.

[6]Giordano FJ,Gerber HP,Williams SP,et al.A cardiac myocyte vascular endothelial growth factor paracrine pathway is required to maintain cardiac function[J].Proc Natl Acad Sci U S A,2001,98(10):5780-5785.

[7]Fujio Yawls K.Akt mediates cytoprotection of endothelial cells by vascular endothelial growth factor in an anchoragedependent manner[J].J Biol Chem,1999, 274(23):16349-16354.

[8]Markel TA,Wang Y,Herrmann JL,et al.VEGF is critical for stem cellmediated cardioprotection and a crucial paracrine factor for defining the age threshold in adult and neonatal stem cell function[J].Am J Physiol Heart Circ Physiol,2008,295(6):H2308-H2314.

[9]Urbich C,Aicher A,Heeschen C,et al.Soluble factors released by endothelial progenitor cells promote migration of endothelial cells and cardiac resident progenitor cells[J].J Mol Cell Cardiol, 2005,39(3):733-742.

[10]曹 青,陈书艳.内源性心脏干细胞的研究进展[J].心脏杂志 2010, 22(1):146-148.

[11]唐俊明,谢祁阳.干细胞迁移到心肌梗死区的调控机制[J].心脏杂志,2004, 16(4):381-383.

[12]Pons J,Huang Y,ArakawaHoyt J,et al.VEGF improves survival of mesenchymal stem cells in infarcted hearts[J].Biochem Biophys Res Commun,2008,376(2):419-422.

[13]Xiang MX,He AN,Wang JA,et al.Protective paracrine effect of mesenchymal stem cells on cardiomyocytes[J].J Zhejiang Univ Sci B,2009,10(8):619-624.

[14]Gnecchi M,Zhang Z,Ni A,et al.Paracrine mechanisms in adult stem cell signaling and therapy[J].Circ Res,2008,103(11):1204-1219.

[15]Abid MR,Guo S,Minami T,et al.Vascular endothelial growth factor activates PI3K/Akt/forkhead signaling in endothelial cells[J].Arterioscler Thromb Vasc Biol,2004,24(2):294-300.

备注/Memo

备注/Memo:
收稿日期:2011-12-19.基金项目:国家自然科学基金项目资助(81170095;30700306) 通讯作者:唐俊明,副教授,主要从事干细胞移植治疗心肌梗死机制研究Email: tangjm416@163.com 作者简介:毛洪波,主治医师Email:104815371@qq.com
更新日期/Last Update: 2013-03-20